MY OPINION: Jumped into SNSS at this low signal of 4.24. This drop in share price occurred after recent earnings report on March 8th. This is a psychological pitfall, expecting shares to jump back between the middle and bottom Bands by mid week.
THE FACTS: The company reported $0.21 earnings per share for the quarter Sunesis Pharmaceuticals has a 52 week low of $1.82 and a 52 week high of $7.69. Among 5 analysts covering Sunesis Pharmaceuticals, 2 have Buy rating, 1 Sell and 2 Hold.
交易進行
⋅
SNSS pushed wayyyy down to 3.5 as of now. Waiting for the bulls to run it back up. Still looking at a PT of 5.00-5.20